Kazi Ahsan Ahmed

Mr. Kazi Ahsan Ahmed

Bangladesh Agricultural University, Mymensingh, Bangladesh
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2021 in Current Oncology
Verified
Journal Article
Open access
PDF file
Kazi Ahsan AhmedKazi Ahsan Ahmed
Kazi Ahsan Ahmed
Tasnin Al HasibTasnin Al Hasib
Tasnin Al Hasib
SPShamrat Kumar Paul
Shamrat Kumar Paul
MSMd. Saddam
Md. Saddam
AMAfsana Mimi
Afsana Mimi
Bonglee KimBonglee Kim
Bonglee Kim
CCNs are a specific type of matricellular protein, which are essential signaling molecules, and play multiple roles in multicellular eukaryotes. This family of proteins consists of six separate members, which exist only in vertebrates. The architecture of CCN proteins is multi-modular comprising four distinct modules. CCN Proteins achieve their primary functional activities by binding with several integrin7 receptors. The CCN family has been linked to cell adhesion, chemotaxis and migration, mitogenesis, cell survival, angiogenesis, differentiation, tumorigenesis, chondrogenesis, and wound healing, among other biological interactions. Breast cancer is the most commonly diagnosed cancer worldwide and CCN regulated breast cancer stands at the top. A favorable or unfavorable association between various CCNs has been reported in patients with breast carcinomas. The pro-tumorigenic CCN1, CCN2, CCN3, and CCN4 may lead to human breast cancer, although the anti-tumorigenic actions of CCN5 and CCN6 are also present. Several studies have been conducted on CCN proteins and cancer in recent years. CCN1 and CCN3 have been shown to exhibit a dual nature of tumor inhibition and tumor suppression to some extent in quiet recent time. Pharmacological advances in treating breast cancer by targeting CCN proteins are also reported. In our study, we intend to provide an overview of these research works while keeping breast cancer in focus. This information may facilitate early diagnosis, early prognosis and the development of new therapeutic strategies.

31 August 2022 in Informatics in Medicine Unlocked
Verified
Journal Article
Open access
MKMushira Khanam
Mushira Khanam
AMAbu Tayab Moin
Abu Tayab Moin
Kazi Ahsan AhmedKazi Ahsan Ahmed
Kazi Ahsan Ahmed
RPRajesh B. Patil
Rajesh B. Patil
AKAbul Bashar Ripon Khalipha
Abul Bashar Ripon Khalipha
BRBashudev Rudra
Bashudev Rudra
Hepatocellular carcinoma (HCC) is the most common malignant condition of the liver that occurs as a result of uncontrolled cellular proliferation after a series of disruptions at cell cycle regulatory checkpoints in the normal cell. Due to the lack of appropriate therapeutics or remedial treatment methods, new treatment strategies against HCC need to be developed. Cyclin dependent kinases (CDKs) are required to control the cell cycle and apoptosis, but their overexpressionis critical in the progression of cancer and is often expressed in HCC. Thus, CDKs are considered a promising class of target-defined therapy for HCC. Milciclib is a potential candidate for HCC which exhibits inhibitory activity against CDK2 leading to cell cycle arrest and apoptosis of tumor cells. Herein, we have halogenated the parent drug milciclib to improve its efficacy against CDK2. The primary structure of milciclib (D) was modified with F, Cl and,CF3 groups. The frontier molecular orbital features, binding affinity, non-bonded interaction and the pharmacokinetic parameters were analyzed for milciclib and its derivatives. We also performed molecular docking and extended molecular dynamics simulation studies to study the binding interactions and binding affinity more closely. Our computational investigation showed the derivatives D-F and D-CF3 have significant chemical reactivity, the best binding affinity, nonbonding interactions, and improved pharmacokinetic properties compared to the parent drug milciclib. Molecular dynamics analysis and MM-PBSA calculations indicated that D-Cl had a slightly more stable conformation and higher binding affinity compared to D-CF3.

1 January 2021 in Journal of Advanced Biotechnology and Experimental Therapeutics
Verified
Journal Article
Closed access
Kazi Ahsan AhmedKazi Ahsan Ahmed
Kazi Ahsan Ahmed
Abu Saim Mohammad SaikatAbu Saim Mohammad Saikat
Abu Saim Mohammad Saikat
AMAkhi Moni
Akhi Moni
SKSadia Kakon
Sadia Kakon
MIMd Islam
Md Islam
MUMd Uddin
Md Uddin

1 January 2022 in The Korean Journal of Physiology & Pharmacology
Verified
Journal Article
Open access
PDF file
Md. Sarwar ZahanMd. Sarwar Zahan
Md. Sarwar Zahan
Kazi Ahsan AhmedKazi Ahsan Ahmed
Kazi Ahsan Ahmed
AMAkhi Moni
Akhi Moni
ASAlessandra Sinopoli
Alessandra Sinopoli
HHHunjoo Ha
Hunjoo Ha
Md Jamal UddinMd Jamal Uddin
Md Jamal Uddin
Kidney disease is becoming a global public health issue. Acute kidney injury (AKI) and chronic kidney disease (CKD) have serious adverse health outcomes. However, there is no effective therapy to treat these diseases. Lactoferrin (LF), a multi-functional glycoprotein, is protective against various pathophysiological conditions in various disease models. LF shows protective effects against AKI and CKD. LF reduces markers related to inflammation, oxidative stress, apoptosis, and kidney fibrosis, and induces autophagy and mitochondrial biogenesis in the kidney. Although there are no clinical trials of LF to treat kidney disease, several clinical trials and studies on LF-based drug development are ongoing. In this review, we discussed the possible kidney protective mechanisms of LF, as well as the pharmacological and therapeutic advances. The evidence suggests that LF may become a potent pharmacological agent to treat kidney diseases.

28 June 2021 in Cancers
Verified
Journal Article
Open access
PDF file
SSSeung-Hee Seo
Seung-Hee Seo
SPShamrat Kumar Paul
Shamrat Kumar Paul
MSMita Shikder
Mita Shikder
MKMushira Khanam
Mushira Khanam
Popy GhoshPopy Ghosh
Popy Ghosh
YKYoungjoo Kwon
Youngjoo Kwon
Glial cells comprise the non-sensory parts of the central nervous system as well as the peripheral nervous system. Glial cells, also known as neuroglia, constitute a significant portion of the mammalian nervous system and can be viewed simply as a matrix of neural cells. Despite being the “Nervenkitt” or “glue of the nerves”, they aptly serve multiple roles, including neuron repair, myelin sheath formation, and cerebrospinal fluid circulation. Ependymal cells are one of four kinds of glial cells that exert distinct functions. Tumorigenesis of a glial cell is termed a glioma, and in the case of an ependymal cell, it is called an ependymoma. Among the various gliomas, an ependymoma in children is one of the more challenging brain tumors to cure. Children are afflicted more severely by ependymal tumors than adults. It has appeared from several surveys that ependymoma comprises approximately six to ten percent of all tumors in children. Presently, the surgical removal of the tumor is considered a standard treatment for ependymomas. It has been conspicuously evident that a combination of irradiation therapy and surgery is much more efficacious in treating ependymomas. The main purpose of this review is to present the importance of both a deep understanding and ongoing research into histopathological features and prognoses of ependymomas to ensure that effective diagnostic methods and treatments can be developed.

10 August 2025 in Pharmacology Research & Perspectives
Verified
Journal Article
Open access
Kazi Ahsan AhmedKazi Ahsan Ahmed
Kazi Ahsan Ahmed
NANusrat Afrin
Nusrat Afrin
PGPopy Ghosh
Popy Ghosh
IHIrin Amin Heya
Irin Amin Heya
SASajidur Rahman Akash
Sajidur Rahman Akash
Md Jamal UddinMd Jamal Uddin
Md Jamal Uddin
Respiratory diseases are associated with high mortality worldwide. Respiratory infections can lead to the emergence of chronic respiratory diseases. Scientists are constantly striving to identify new therapies with reduced side effects. The rise of antibiotic resistance and the scarcity of effective treatments further necessitate the development of novel therapeutics specific to respiratory diseases. Extensive research has been conducted on natural products that could be effective against respiratory diseases. Mangiferin, a polyphenol with a C‐glycosyl xanthone structure, is a bioactive phytochemical that has potential applications in the treatment of respiratory tract infections. Mangiferin could be a therapeutic option against respiratory diseases because of its ability to target a variety of pharmacological pathways implicated in the development of these infections. It has been shown to limit infections, lower inflammation, control immune responses, and enhance host defense mechanisms. This review provides comprehensive insight into mangiferin's potential against various respiratory disorders, focusing on its pharmacological activity and therapeutic prospects. Despite the potential of mangiferin against respiratory problems‐related pathobiology, additional scientific validation through clinical trials is required before the clinical application of mangiferin in the management of respiratory diseases.